Clopidogrel Tablet
Product Images NDC 50090-5781

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Clopidogrel (NDC 50090-5781). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

189 (Clopidogrel Fig 3)

FDA Label Image

Figure-1 (Clopidogrel Figure 01)

FDA Label Image

Figure-2 (Clopidogrel Figure 02)

Figure-2 (Clopidogrel Figure 02)
This is a graph that compares two types of medication - Placebo (with aspirin) and Clopidogrel (with aspirin). The graph shows the number of months of follow-up on the x-axis and the probability of an event (not specified) on the y-axis. The values on the y-axis range from 0 to 0.00009. Other standard therapies were used as needed while conducting the study.*
FDA Label Image

Figure-4 (Clopidogrel Figure 04)

Figure-4 (Clopidogrel Figure 04)
This appears to be a summary of data from a study comparing the use of a drug (Clopidogrel) to a placebo in patients who were also given aspirin. Both groups had a certain number of deaths, and it is stated that the Clopidogrel group had a 7% risk reduction compared to the placebo group (with a p-value of 0.03). The graph appears to show the number of days since randomization in the study. There is not enough context to determine the purpose of the study or the nature of the condition being treated.*
FDA Label Image

146 (Clopidogrel Figure 05)

FDA Label Image

Fig-7 (Clopidogrel Figure 07)

Fig-7 (Clopidogrel Figure 07)
This is a report of a clinical study comparing the effectiveness of aspirin and clopidogrel, with a p-value of 0.045 indicating a statistically significant difference between the two treatments. The study was conducted for a period of several months but the exact duration is not specified.*
FDA Label Image

Figure-3 (Clopidogrel Figure 3)

Figure-3 (Clopidogrel Figure 3)
This is a table with numerical values that seems to relate to a study or research which includes the administration of a drug called Clopidogrel and a placebo. The table provides the results of the study, with some values being favorable towards the placebo group. There is also a reference to a location called Ratho G5, but it's not clear how it is related to the study.*
FDA Label Image

Figure-6 (Clopidogrel Figure 6)

FDA Label Image

Figure-8 (Clopidogrel Figure 8)

FDA Label Image

Structure (Clopidogrel Structure)

FDA Label Image

Label Image (Lbl500905781)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.